DCF — BAYLOR S&W ALL SAINTS MEDICAL CENTER
Enterprise Value: $141.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$141.1M
Enterprise Value
$28.1M
PV of Cash Flows
$113.0M
PV of Terminal Value
$181.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $536.9M | $26.8M | 5.0% | $0.8M | $0.7M |
| Year 2 | $553.0M | $33.2M | 6.0% | $4.9M | $4.1M |
| Year 3 | $569.6M | $39.9M | 7.0% | $9.3M | $7.0M |
| Year 4 | $586.7M | $44.0M | 7.0% | $11.8M | $8.1M |
| Year 5 | $604.3M | $46.8M | 8.0% | $13.3M | $8.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $141.1M. Terminal value accounts for 80% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$521.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.04497346544113728
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5